Keywords
Naprotechnology
recurrent miscarriage
predictors of success
restorative reproductive medicine.
How to Cite
Abstract
Objective: To assess the outcomes of treatment the couples with infertility or recurrent miscarriage with restorative reproductive approach and to identify predictors of success. Methods: It was a retrospective study of 282 married couples, who were included in the program in 2 outpatient gynaecological centers in May 2010 - December 2014. The couples were observed to the end of pregnancy (or pregnancies) or withdrawal from the program. All the couples were taught to track the cycle with the Creighton Model FertilityCare System or the sympto-thermal method, and almost all received additional medical treatment. The main outcome was live birth, the secondary outcomes included conceptions, unsuccessful pregnancies, low birth weight and prematurity. Results: In life-table analysis, the adjusted cumulative proportion of first conceptions for those completing up to 24 months of NPT treatment was 77,7% (crude proportion 47.9%). The adjusted cumulative proportion of live births (included only women whose first pregnancy in the program was successful) was 73.6% (117 births, crude proportion 41.5%). The crude proportion of first live births (124 births, including
7 live births in women whose first pregnancy result was miscarriage) was 44%. Mean time to achieving pregnancy was 8 months (from 1 to 44 month). All the births except one were singleton. There were only 3 preterm births (gestational age less than 36 weeks) with one of them in the mentioned twin pregnancy. Only the babies of these 3 pregnancies were born with weight less than 2500 g.
The favorable predictors of live birth were younger age, shorter time of trying for baby, good compliance, pregnancy in history. The unfavorable were hyperprolactinemia, uterine fibroids, endometriosis, male factor. Conclusion: The outcomes of restorative reproductive treatment the couples with infertility or recurrent miscarriage in Ukraine were comparable to those in Ireland and Canada.
References
Apolicy Audit on Fertility Analysis of 9 EU Countries March (2017). Supported by: Sponsored by Merck KGaA, Darmstadt, Germany. https://www.slideshare.net/SOSInfertilitatea/european-policy-audit-on-fertility.
ASRM Practice Committee/Diagnostic evaluation of the infertile female: a committee opinion. (2015). Fertility and Sterility, 103, 6, 0015-0282.
Bewley, S., Foo, L., Braude, P. (2011). Adverse outcomes from IVF, British Medical Journal, 342, d436 . https://doi.org/10.1136/bmj.d436.
Bodri, D., Kawachiya, S., De Brucker, M., Tournaye, H., Kondo, M., Kato, R., Matsumoto, T. (2024). Cumulative success rates following mild IVF in unselected infertile patients: a 3-year, single-centre cohort study, Reproductive BioMedicine Online, 28, 5, 572–581. https://doi.org/10.1016/j.rbmo.2014.01.002.
Chambers, G.M., Paul, R.C., Harris, K., et al. (2017). Assisted reproductive technology in Australia and New Zealand: cumulative live birth rates as measures of success, The Medical Journal of Australia, 207 (3), 114–118. https://doi.org/10.5694/mja16.01435.
Cortesi, S., Rigoni, G., Zen, F., Sposetti, R. (1981). Correlation of plasma gonadotrophins and ovarian steroids pattern with symptomatic changes in cervical mucus during the menstrual cycle in normal cycling women, Contraception, 23 (6), 629-641. https://doi.org/10.1016/s0010-7824(81)80005-4.
De Geyter, C., Calhaz-Jorge, C., Kupka, M.S., et al. (2015). ART in Europe: results generated from European registries by ESHRE. The European IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE) Human Reproduction Open, 1–17. https://doi.org/10.1093/hropen/hoz038.
Depares, J., Ryder, R.E., Walker, S.M., Scanlon, M.F., Norman, C.M. (1986). Ovarian ultrasonography highlights precision of symptoms of ovulation as markers of ovulation, British Medical Journal, 292 (6535), 1562.
Ecochard, R., Boehringer, H., Rabilloud, M., Marret, H. (2001). Chronological aspects of ultrasonic, hormonal, and other indirect indices of ovulation, An International Journal of Obstetrics and Gynaecology, 108 (8), 822-829. https://doi.org/10.1111/j.1471-0528.2001.00194.
Fehring, R.J. (2005). New low- and high-tech calendar methods of family planning. J Midwifery Womens Health, 50 (1), 31-8. https://doi.org/10.1016/j.jmwh.2004.07.001.
Ferraretti, A.P., Nygren, K., Nyboe Andersen A., et al. (2017). The European IVF-Monitoring Consortium (EIM), for the European Society of Human Reproduction and Embryology (ESHRE), Trends over 15 years in ART in Europe: an analysis of 6 million cycles, Human Reproduction Open, 2, https://doi.org/10.1093/hropen/hox012.
Frank-Herrmann, P., Jacobs, C., Jenetzky, E., Gnoth, C., Pyper, C., Baur, S., Freundl, G., Goeckenjan, M., Strowitzki, T. (2017). Natural conception rates in subfertile couples following fertility awareness training, Archives of Gynecology and Obstetrics, 295 (4), 1015-1024. https://doi.org/10.1007/s00404-017-4294-z.
Gameiro, S., van den Belt-Dusebout, A.W., Bleiker, E., Braat, F., Leeuwen, F.E., Verhaak, C.M. (2014). Do children make you happier? Sustained child-wish and mental health in women 11–17 years after fertility treatment, Human Reproduction, 29, 10, 2238–2246. https://doi.org/10.1093/humrep/deu178.
Grady, R., Alavi, N., Vale, R., Khandwala, M., McDonald, S.D. (2012). Elective single embryo transfer and perinatal outcomes: a systematic review and meta-analysis, Fertility and Sterility, 97 (2), 324-331. https://doi.org/10.1016/j.fertnstert.2011.11.033.
Hilgers, T.W., Abraham, G.E., Cavanagh, D. (1978). Natural family planning. I. The peak symptom and estimated time of ovulation. Obstetrics & Gynecology, 52 (5), 575-582. PMID: 724176.
Hilgers, T.W. (2004). The medical and surgical practice of NaProTechnology. Omaha, NE: Pope Paul VI Institute Press.
Hilgers, T.W., Prebil, A.M. (1979). The ovulation method—vulvar observations as an index of fertility/infertility, Obstetrics & Gynecology, 53 (1), 12-22. PMID: 760010.
Huang, L.N., Tan, J., Hitkari, J., Dahan, M.J. (2015). Should IVF be used as first-line treatment or as a last resort? A debate presented at the 2013 Canadian Fertility and Andrology Society meeting, Reproductive BioMedicine Online, 30, 2, 128–136. https://doi.org/10.1016/j.rbmo.2014.10.004.
Lande, Y., Seidman, D.S., Maman, E., Baum, M., Dor, J., Hourvitz, A. (2011). Couples offered free assisted reproduction treatment have a very high chance of achieving a live birth within 4 years, Fertility and Sterility, 95, 568-72. https://doi.org/10.1016/j.fertnstert.2010.06.005.
Leader, A., Wiseman, D., Taylor, P.J. (1985). The prediction of ovulation: a comparison of the basal body temperature graph, cervical mucus score, and real-time pelvic ultrasonography, Fertility and Sterility, 43 (3), 385-388. https://doi.org/10.1016/s0015-0282(16)48436-0.
Luke, B., Brown, M.B., Wantman, E., Lederman, A., Gibbons, W., Schattman, G.L., Lobo, R.A., Leach, R.E., and Stern, J.E. (2012). Cumulative birth rates with linked assisted reproductive technology cycles, The New England Journal of Medicin, 366, 2483–2491. https://doi.org/10.1056/NEJMoa1110238.
Malizia, B.A., Hacker, M.R., Penzias, A. (2009). Cumulative live-birth rates after in vitro fertilization, The New England Journal of Medicin, 360, 236-43. https://doi.org/10.1056/NEJMoa0803072.
Martin, A.S., Chang, J., Zhang, Y., Kawwass, J.F., Boulet, S.L., McKane, P., Bernson, D., Kissin, D.M., Jamieson, D.J. (2017). States Monitoring Assisted Reproductive Technology (SMART) Collaborative. Perinatal outcomes among singletons after assisted reproductive technology with single-embryo or double-embryo transfer versus no assisted reproductive technology, Fertility and Sterility, 107 (4), 954-960. https://doi.org/10.1016/j.fertnstert.2017.01.024.
McDonald, S.D., Han, Z., Mulla, S., Murphy, K.E., Beyene, J., Ohlsson, A. (2009). Knowledge Synthesis Group. Preterm birth and low birth weight among in vitro fertilization singletons: a systematic review and meta-analyses, European Journal of Obstetrics & Gynecology and Reproductive Biology, 146 (2), 138-48. https://doi.org/10.1016/j.ejogrb.2009.05.035.
Snick, H.K., Snick, T.S., Evers, J.L., Collins, J.A. (1997). The spontaneous pregnancy prognosis in untreated subfertile couples: the Walcheren primary care study, Human Reproduction, 12 (7), 1582-1588. https://doi.org/10.1093/humrep/12.7.1582.
Soullier, N., Bouyer, J., Pouly, J.L., de La Guibert, J., Rochebrochard, E. (2011). Effect of the woman’s age on discontinuation of IVF treatment, Reproductive BioMedicine Online, 22, 496–500. https://doi.org/10.1016/j.rbmo.2011.01.013.
Stanford, J.B., Willis, S.K., Hatch, E.E., Rothman, K.J., Wise L.A. (2019). Fecundability in relation to use of fertility awareness indicators in a North American preconception cohort study, Fertility and Sterility, 112, 892–899. https://doi.org/10.1016/j.fertnstert.2019.06.036.
Stanford, J.B., Parnell, T.A., Boyle, P.C. (2008). Outcomes from treatment of infertility with natural procreative technology in an Irish general practice, Journal of the American Board of Family Medicine, 21 (5), 375-84. Erratum in: Journal of the American Board of Family Medicine, 21 (6), 583. https://doi.org/10.3122/jabfm.2008.05.070239.
Stanford, J.B., White, G.L., Hatasaka, H. (2002). Timing intercourse to achieve pregnancy: current evidence, Obstetrics & Gynecology, 100 (6), 1333-1341.
Stanford, J.B. (2019). Restorative Reproductive Medicine: what does it take to be medical discipline? 16th Annual General Meeting & International Conferencee for Restorative Reproductive Medicine, Dublin, Ireland. https://iirrm.org/dublin/.
Stockij, S.S. (2016). Analysis of risk factors of different forms of infertility in women of reproductive age. The Pharma Innovation Journal, 5 (1), 33-34. www.thepharmajournal.com. ISSN: 2277- 7695.
Tham, E., Schliep, K., Stanford, J. (2012). Natural procreative technology for infertility and recurrent miscarriage: Outcomes in a Canadian family practice, Canadian Family Physician, 58, e267-74. PMID: 22734170.
Toftager, M., Bogstad, J., Løssl, K., Prætorius, L., Zedeler, A., Bryndorf, T., Nilas, L., Pinborg, A. (2017). Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols, Human Reproduction, 1, 32 (3), 556-567. https://doi.org/10.1093/humrep/dew358.
Woo, I., Hindoyan, R., Landay, M., Ho, J., Ingles, S.A., Mcginnis, L.K., et al. (2017). Perinatal outcomes after natural conception versus in vitro fertilization (IVF) in gestational surrogates: a model to evaluate IVF treatment versus maternal effects, Fertility and Sterility, 108, 993–998. https://doi.org/10.1016/j.fertnstert.2017.09.014.
Zinaman, M.J. (2006). Using cervical mucus and other easily observed biomarkers to identify ovulation in prospective pregnancy trials, Paediatric and Perinatal Epidemiology, 20 (1), 26-29. https://doi.org/10.1111/j.1365-3016.2006.00767.
Zukin, V. (2016). Epidemiology of infertility. https://www.eshre.eu/~/media/sitecore-files
https://www.eggdonationfriends.com/ivf-egg-donation-country-ukraine/.
Review of the 35th European Society of Human Reproduction and Embryology (ESHRE) Congress 2019. https://emj.emg-health.com/wp. content/uploads/sites/2/2019/08/ESHRE-Review-2019.pdf.